Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1061-1070 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|August 26, 2016
Techno-economic analysis of a transient plant-based platform for monoclonal antibody productionSomen Nandi, Aaron T Kwong, Barry R Holtz, et al.
Mabs|February 25, 2010
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, SwitzerlandAlain Beck, Janice M Reichert, Thierry Wurch
Mabs|January 19, 2010
Oligomeric forms of single chain immunoglobulin (scIgG)Thomas Schirrmann, Christian Menzel, Michael Hust, et al.
Mabs|January 12, 2010
New methods allowing the detection of protein aggregates: a case study on trastuzumabBarthélemy Demeule, Caroline Palais, Gia Machaidze, et al.
Mabs|January 12, 2010
Immunotherapy for Alzheimer diseaseGunnar K Gouras
Mabs|January 12, 2010
mAbs: a business perspectivePablo A Scolnik
Mabs|January 12, 2010
Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsJutta Steigerwald, Tobias Raum, Stefan Pflanz, et al.
Mabs|January 12, 2010
High level expression of functional human IgMs in human PER.C6 cellsAnna Tchoudakova, Frank Hensel, Alec Murillo, et al.
Mabs|January 12, 2010
Monoclonal antibody to dengue capsid protein: its application in dengue studiesY Vazquez, Maritza Pupo-Antúnez, S V Vazquez, et al.
Mabs|January 13, 2010
Guardians at the gate: Biosimilar and patent reform legislation could fundamentally change the guards for therapeutic monoclonal antibodies--Part 2Kevin W McCabe
Pageof 184

Showing results (1061-1070 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|August 26, 2016
Techno-economic analysis of a transient plant-based platform for monoclonal antibody productionSomen Nandi, Aaron T Kwong, Barry R Holtz, et al.
Mabs|February 25, 2010
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, SwitzerlandAlain Beck, Janice M Reichert, Thierry Wurch
Mabs|January 19, 2010
Oligomeric forms of single chain immunoglobulin (scIgG)Thomas Schirrmann, Christian Menzel, Michael Hust, et al.
Mabs|January 12, 2010
New methods allowing the detection of protein aggregates: a case study on trastuzumabBarthélemy Demeule, Caroline Palais, Gia Machaidze, et al.
Mabs|January 12, 2010
Immunotherapy for Alzheimer diseaseGunnar K Gouras
Mabs|January 12, 2010
mAbs: a business perspectivePablo A Scolnik
Mabs|January 12, 2010
Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsJutta Steigerwald, Tobias Raum, Stefan Pflanz, et al.
Mabs|January 12, 2010
High level expression of functional human IgMs in human PER.C6 cellsAnna Tchoudakova, Frank Hensel, Alec Murillo, et al.
Mabs|January 12, 2010
Monoclonal antibody to dengue capsid protein: its application in dengue studiesY Vazquez, Maritza Pupo-Antúnez, S V Vazquez, et al.
Mabs|January 13, 2010
Guardians at the gate: Biosimilar and patent reform legislation could fundamentally change the guards for therapeutic monoclonal antibodies--Part 2Kevin W McCabe
Pageof 184